Welcome to the Pharmacy Homepage
The Colorado State Board of Pharmacy regulates pharmacists, pharmacy interns, pharmacy technicians, in-state and nonresident pharmacies, in-state and out-of-state prescription drug wholesalers, satellite pharmacies, specialized prescription drug outlets, other outlets, and limited licenses. The Board upholds consumer protection by licensing qualified applicants, investigating complaints, and enforcing disciplinary actions against violators of the Pharmacists, Pharmacy Business and Pharmaceuticals Act and the Board's rules.
The Board consists of five pharmacist members and two public members and works in conjunction with the Federal Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), Colorado Pharmacists Society, RxPlus Pharmacies, and the Colorado Retail Council.
Program Information
- Program/Board Members
Dmitry Kunin, Senior Program Director
State Board of Pharmacy
1560 Broadway, Suite 1350
Denver, CO 80202Phone: 303-894-7800 | Fax: 303-894-7692 | Email: dora_pharmacyboard@state.co.us
Board Members:
- Patricia A.Evacko, PharmD., President
Term Expires: July 1, 2026 - Kristen Wolf, PharmD, BCSCP, Vice President
Term Expires: July 1, 2027 - Avani Soni, Pharm.D., RPh
Term Expires: July 1, 2025 - Michael Scruggs, Pharm.D
Term Expires: July 1, 2025 - Ryan Leyland, PharmD, RPh
Term Expires: July 1, 2027 - Alexandra Zuccarelli, MBA
Term Expires: July 1, 2027 - Jayant Patel
Term Expires: July 1, 2027
- Patricia A.Evacko, PharmD., President
- Public Notices
Stakeholder Meeting – December 16, 2024
The purpose of this Stakeholder Meeting is for the Board to receive feedback on proposed new Rule 17.00.00, Appendix G – MAT Prescription Protocol - The purpose is to create a new MAT Prescribing Statewide Protocol that is required as part of implementation of Colorado House Bill 24-1045.
- Monday, December 16, 2024, at 2:00 P.M. (MDT)
- Stakeholder Meeting Notice
- Draft Rules
- HB24-1045
- Written comments (Link will be updated as comments are received.)
- Stakeholder Meeting Recording - December 16, 2024
Rulemaking Hearing – October 3, 2024
The purpose of this Rulemaking Hearing is to allow stakeholders a final opportunity to testify before the Board determines on proposed changes to Rules 14.00.00, 15.00.00, 17.00.00, 21-00-00, 17(Appendix A), 3.00.00, 23.00.00, 11.00.00, proposed new Rule 17.00.00(Appendix E & F) to implement HB24-1045, and proposed changes to Rules 2.00.00, 3.00.00 & 31.00.00, to implement Colorado Senate Bill 24-209.
- Rules adopted on October 3, 2024 can be found here and are anticipated to go into effect November 30, 2024
- Thursday, October 3, 2024, at 9:00 A.M. (MDT)
- Rulemaking Hearing Notice
- Draft Rules
- Webinar Registration
- Written comments (Link will be updated as comments are received.)
- Recording - Stakeholder Meeting – August 19, 2024
Stakeholder Meeting – August 19, 2024
The purpose of this Stakeholder Meeting is for the Board to receive feedback on proposed changes to Rules 14.00.00, 15.00.00, 17.00.00, 21-00-00, 17(Appendix A), 3.00.00, 23.00.00, 11.00.00, proposed new Rule 17.00.00(Appendix E & F) to implement HB24-1045, and proposed changes to Rules 2.00.00, 3.00.00 & 31.00.00, to implement Colorado Senate Bill 24-209.
- Monday, August 19, 2024, at 10:00 A.M. (MDT)
- Stakeholder Meeting Notice
- Draft Rules
- Webinar Registration
- Written comments (Link will be updated as comments are received.)
- Recording - Stakeholder Meeting - August 19, 2024
Permanent Rulemaking Hearing – January 18, 2024
The purpose of the Permanent Rulemaking Hearing is to receive testimony before the Board determines whether to adopt proposed revisions and additions to Rule 14 - OTHER OUTLETS. The purpose of the proposed revisions and additions are "to clarify organizations utilizing an Other Outlet license type on record keeping requirements with mobile drug delivery and administration."
- Thursday, January 18, 2024, at 9:00 A.M. (MDT)
- Permanent Rulemaking Hearing Notice
- Draft Rules
- Webinar Registration
- Written comments (Link will be updated as comments are received.)
REQUESTING WRITTEN STAKEHOLDER COMMENTS
Colorado Board of PharmacyWhat is this about?
The Colorado Board of Pharmacy ("Board") is requesting written comments regarding proposed revisions and additions to Rule 14 - OTHER OUTLETS. The purpose of the proposed revisions and additions are "to clarify organizations utilizing an Other Outlet license type on record keeping requirements with mobile drug delivery and administration." The Board will hold a Rulemaking Hearing on January 18, 2024, to determine whether to adopt the proposed revisions and additions to Rule 14 - OTHER OUTLETS on a permanent basis. Please submit written comments to dora_dpo_rulemaking@state.
co.us by December 15, 2023, however the Board will continue to accept written comments until the Rulemaking Hearing on January 18, 2024. Written comments will be posted on the Board's website under the "Public Notices" tab as received for all stakeholders to access and review.Permanent Rulemaking Hearing - October 5, 2023
The purpose of the Permanent Rulemaking Hearing is to receive testimony before the Board determines whether to repeal Rules 32.00.00 - PROTECTIONS FOR PROVISION OF REPRODUCTIVE HEALTH CARE IN COLORADO and 33.00.00 - PROTECTING COLORADO’S WORKFORCE AND EXPANDING LICENSING OPPORTUNITIES on a permanent basis to implement Colorado Senate Bill 23-188 (Concerning Protections for Accessing Reproductive Health Care) and Colorado Senate Bill 23-265 (Concerning a Prohibition on a Regulator Imposing Discipline Against a Person Based on Certain Activities Involving Marijuana). And to consider proposed changes to: Rule 5.01.40 – OUTLETS, Rule 11.06.10 – RECORDS AND RECORKEEPING, Rule 19.01.10 – ADMINISTRATION, Rules 1, 5, 11, 14, 21, 26, 27, 29, and 30 – PROFESSIONAL CONDUCT, OUTLETS, RECORDS AND RECORDKEEPING, OTHER OUTLETS, COMPOUNDING, REMOTE PHARMACY PRACTICE, HOSPITAL PHARMACY SATELLITE, PHARMACY TECHNICIANS, COVID-19 HEALTH RESPONSE RULE, Rule 23.00.70 – ELECTRONIC PRESCRIPTION MONITORING PROGRAM, Rule 3, 11, 17, 20, and 21 – DISPENSING, RECORDS AND RECORDKEEPING, COLLABORATIVE PHARMACY PRACTICE, CENTRAL PRESCRIPTION PROCESSING, and COMPOUNDING, Rule 5 – OUTLETS, Rule 2 – ORDERS, Rule 3 – DISPENSING, Rule 5 – OUTLETS, Rule 12 - NUCLEAR PHARMACY, and Rule 21 – COMPOUNDING.
- Thursday, October 5, 2023, at 9:00 A.M. (MDT)
- Permanent Rulemaking Hearing Notice
- Draft Rules
- Written comments (Link will be updated as comments are received.)
- Stakeholder Meeting Recording - August 21, 2023 10:00 A.M.
- Stakeholder Meeting Recording - August 21, 2023 1:00 P.M
Emergency and Permanent Rulemaking Hearing - September 21, 2023
The Board of Pharmacy held a Rulemaking Hearing to allow stakeholders a final opportunity to testify before the Board determined whether to adopt the proposed new Rule 33.00.00 (RULES AND REGULATIONS REGARDING GENERALLY ACCEPTED STANDARDS OF PHARMACY PRACTICE REGARDING PREGNANCY-RELATED SERVICES) to implement Colorado Senate Bill 23-190(opens in new window) (Concerning Policies to Make Punishable Deceptive Actions regarding Pregnancy-Related Services.
- Adopted Rule 33.00.00 - Effective October 1, 2023
- Written Comments(opens in new window) (Link will be updated as comments are received.)
- Legislative Updates
- 2024 New Legislation
- HB 24-1004: Ex-Offenders Practice in Regulated Occupations
- HB 24-1097: Military Family Occupational Credentialing
- HB 24-1342: Test Accommodations for Persons with Disabilities
- SB 24-129: Non Profit Information Sharing
- SB 24-141: Out of State Telehealth Providers
- HB 24-1045: Treatment for Substance Use Disorders
- SB 24-047: Prevention of Substance Use Disorders
- HB 24-1003: Opiate Antagonists and Detection
Products in Schools - HB 24-1037: Substance Use Disorders Harm Reduction
- HB 24-1115: Prescription Drug Label Accessibility
- HB 24-1438: Implement Prescription Drug Affordability Programs
- HB 24-1450: Revisor’s Bill
- SB 24-209: Pharmacy Practice Act
- 2023 New Legislation
- HB 23-1002: Epinephrine Auto Injectors
- HB23-1071: Licensed Psychologist Psychotropic Medication Prescribing
- HB 23-1195: Automated Pharmacy Dispensing System
- SB23-102: Rule Review Bill
- SB 23-144: Prescription Drugs for Chronic Pain
- SB 23-162: Increase Access to Pharmacy Services
- SB 23-176: Protections for People with Eating Disorders
- SB23-265: SB 23-265: Prohibit Professional Discipline for Marijuana
- SB 23-286: Access to Government Records
- 2022 New Legislation
- HB22-1041: Privacy Protections For Protected Persons
- HB22-1098: Department Of Regulatory Agencies Barriers To Practice Regulated Professions
- HB22-1115: Prescription Drug Monitoring Program
- HB22-1165: Rule Review Bill
- HB22-1240: Mandatory Reporters
- HB22-1246: Hospice Inpatient Unit Specialized Prescription Drug Outlet
- HB22-1257: 2022 Criminal And Juvenile Justice Commission Recommendations
- HB22-1267 Culturally Relevant Training Health Professionals
- HB22-1270: Change Term Name-based Criminal History Record Check
- HB22-1278: Behavioral Health Administration
- HB22-1309: Hospital Dispense Drugs To Sexual Assault Victims
- HB22-1326: Fentanyl Accountability And Prevention
- HB22-1291: Sunrise Review Professions Occupations
- SB22-013: Boards and Commissions
- SB22-027: Prescription Drug Monitoring Program
- SB22-076: Complaint Occupational License Official Acts
- SB22-098 Program Allowing Redispensing Of Unused Drugs
- SB22-116 Increase Occupational Credential Portability
- SB22-140 Expansion Of Experiential Learning Opportunities
- SB22-143 Update Common Provision Term Regulator Title 12
- SB22-162: Administration Organization Act Modernization
- SB22-173: Telepharmacy Criteria Remove Location Restriction
- SB22-174: Sunset Review Hearing Criteria
- SB22-226: Programs To Support Health-care Workforce
- 2021 New Legislation
- HB21-1012 Expand Prescription Drug Monitoring Program
- HB21-1198: Healthcare Billing Requirements for Indigent Patients
- HB 21-1123: CAPS Check for Substantiated Cases of Mistreatment of an At-Risk Adult
- HB21-1169: Prohibit Discrimination Organ Transplant Recipient
- HB21-1232: Standardized Health Benefit Plan Colorado Option
- HB21-1276 Prevention of Substance Use Disorders
- HB21-1297: Pharmacy Benefit Manager and Insurer Requirements
- HB21-1300: Health-care Provider Liens for Injured Persons
- HB21-1307: Prescription Insulin Pricing And Access
- SB21-011: Pharmacist Prescribe Dispense Opiate Antagonist
- SB21-077: Remove Lawful Presence Verification Credentialing
- SB21-094: Sunset Continue State Board of Pharmacy
- SB21-097: Sunset Medical Transparency Act
- SB21-098: Sunset Prescription Drug Monitoring Program
- SB21-122: Opiate Antagonist Bulk Purchase And Standing Orders
- SB21-123: Expand Canadian Rx Import Program
- SB21-271: Misdemeanor Reform
- 2024 New Legislation
- Meeting Minutes
Board Meeting Minutes
- October 3, 2024, Pharmacy Board Meeting Minutes
- September 19, 2024, Pharmacy Board Meeting Minutes
- July 18, 2024, Pharmacy Board Meeting Minutes
Veterinary Pharmaceutical Advisory Committee (VPAC) Minutes